Catalyst Wire Dossier Catalyst Wire Dossier

Denufosol tetrasodium intravitreal injection

denufosol tetrasodium · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Denufosol tetrasodium intravitreal injection, covering 2013-05-21 to 2013-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema [Phase 2]

See pricing